The Patent Finder
EM

Emmecell, Inc.

First filing 2015
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Five patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Mar 2035. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2035
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2019 to 2037.
US 11,737,916 Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same Mar 5, 2035
US 11,740,239 Identification and Isolation of Human Corneal Endothelial Cells (HCECS) Jun 29, 2035
US 10,327,945 Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same Nov 24, 2035
US 10,655,102 Identification and Isolation of Human Corneal Endothelial Cells (HCECS) Oct 6, 2036
US 10,478,332 Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same Mar 14, 2037
20232027203120352037
4 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 25, 2026
    The maintenance fee for Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same (US 10,327,945) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
  • 2 fees due Feb 28, 2027
  • 1 fee due May 19, 2027
    The maintenance fee for Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same (US 10,478,332) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 5 of 5

PatentTitleStatusExpiresConfidence
US 11,737,916Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same
In force
 · Medium confidence
In forceMedium confidence
US 11,740,239Identification and Isolation of Human Corneal Endothelial Cells (HCECS)
In force
 · High confidence
In forceHigh confidence
US 10,327,945Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same
In force
 · Medium confidence
In forceMedium confidence
US 10,655,102Identification and Isolation of Human Corneal Endothelial Cells (HCECS)
In force
 · High confidence
In forceHigh confidence
US 10,478,332Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 5: 4 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited